Correlation Between Health Biotchnology and Emerging Markets
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Emerging Markets at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Emerging Markets into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Emerging Markets Growth, you can compare the effects of market volatilities on Health Biotchnology and Emerging Markets and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Emerging Markets. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Emerging Markets.
Diversification Opportunities for Health Biotchnology and Emerging Markets
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Health and Emerging is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Emerging Markets Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emerging Markets Growth and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Emerging Markets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emerging Markets Growth has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Emerging Markets go up and down completely randomly.
Pair Corralation between Health Biotchnology and Emerging Markets
Assuming the 90 days horizon Health Biotchnology is expected to generate 1.66 times less return on investment than Emerging Markets. But when comparing it to its historical volatility, Health Biotchnology Portfolio is 1.17 times less risky than Emerging Markets. It trades about 0.03 of its potential returns per unit of risk. Emerging Markets Growth is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 635.00 in Emerging Markets Growth on September 12, 2024 and sell it today you would earn a total of 63.00 from holding Emerging Markets Growth or generate 9.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Health Biotchnology Portfolio vs. Emerging Markets Growth
Performance |
| Timeline |
| Health Biotchnology |
| Emerging Markets Growth |
Health Biotchnology and Emerging Markets Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Health Biotchnology and Emerging Markets
The main advantage of trading using opposite Health Biotchnology and Emerging Markets positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Emerging Markets can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emerging Markets will offset losses from the drop in Emerging Markets' long position.| Health Biotchnology vs. Vanguard Health Care | Health Biotchnology vs. Vanguard Health Care | Health Biotchnology vs. T Rowe Price | Health Biotchnology vs. T Rowe Price |
| Emerging Markets vs. Fidelity Advisor Health | Emerging Markets vs. Health Biotchnology Portfolio | Emerging Markets vs. Allianzgi Health Sciences | Emerging Markets vs. Lord Abbett Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance |